VUZI Q1 2026 Earnings EPS Beat and Narrowed Loss Boost Investor Sentiment PYPD Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances MBINN Q1 2026 Earnings EPS Surpasses Estimates Amid Market Challenges Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress VST Q1 2026 Earnings Massive EPS Beat Propels Shares Higher CCID Q1 2026 Earnings Preferred Shares Rise Despite Significant EPS Miss